Boehringer Ingelheim open new plant in Catalonia

pharmafile | June 17, 2019 | News story | Sales and Marketing Boehringer Ingelheim, Catalonia, Sant Cugat de Valles, barcelona, pharma 

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona.

The new plant will manufacture Boehringer Ingelheim’s COPD and asthma drug Respimat.

The Catalonia facility has seen Boheringer invest €120 million into the new plant which will see the creation of up to 200 new jobs.

Peter Ploeger, Managing Director of Boehringer Ingelheim Spain, commented: “This new plant is a recognition of the excellence and professionalism of hundreds of workers who, through their dedication, efforts, and commitment, have positioned the Boehringer Ingelheim facilities in Sant Cugat as one of the Group’s European innovation hubs, and a global leader due to its excellence, quality and environmental standards.”

The 17,000 sqm facility will include production areas, laboratories, technical areas, warehouses and an office.

Louis Goss

Related Content

FDA approves Eli Lilly and Boehringer Ingelheim’s Jardiance for chronic kidney disease treatment

Eli Lilly and Boehringer Ingelheim have announced that the US Food and Drug Administration (FDA) …

FDA approves IMIDEX’s AI-powered device VisiRad XR

The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …

Artiva Biotherapeutics announces FDA clearance of IND for AlloNK and Rituximab combo

On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeutics’ …

Latest content